The ‘Spotlight on Neuroendocrine Cancer’ campaign aims to raise awareness of neuroendocrine cancer among non-neuroendocrine cancer specialist healthcare professionals. The campaign collaborates with the UK and Ireland Neuroendocrine Tumour Society (UKINETS). To enable...
NELMAS – An international multi-centre, stratified, open, randomized, comparator-controlled, parallel-group phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best supportive care in patients after resection of neuroendocrine liver...
Final results, published by Ipsen, Monday 16th September. The number of people newly diagnosed with NETs is believed to be rising due to increasing awareness and better methods of diagnosis, with approximately 35 in every 100,000 people currently living with NETs...
At Neuroendocrine Cancer UK, we have been actively collaborating with our charity partners to tackle the urgent need to resolve the ongoing shortages of Pancreatic Enzyme Replacement Therapy (PERT). Our joint efforts have resulted in significant strides towards...
